BIOSANTE PHARMACEUTICALS INC (BPAX) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 43 transactions totaling $997.5K, demonstrating a bullish sentiment with $997.5K in net insider flow. The most recent transaction on Jun 19, 2013 involved a transaction of 16,918,469 shares valued at $0.
No significant insider buying has been recorded for BPAX in the recent period.
No significant insider selling has been recorded for BPAX in the recent period.
Based on recent SEC filings, insider sentiment for BPAX is bullish with an Insider Alignment Score of 100/100 and a net flow of $997.5K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BIOSANTE PHARMACEUTICALS INC (BPAX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading BPAX stock, having executed 43 transactions in the past 90 days. The most active insider is Ross J. Mangano (Executive), who has made 9 transactions totaling $1.1M.
Get notified when executives and directors at BPAX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 19, 2013 | Partners II Lp Meridian Venture | Executive | Award | 16,918,469 | $N/A | $0 | |
| Jun 19, 2013 | Marshbanks Tracy | Executive | Award | 138,091 | $N/A | $0 | |
| Jun 19, 2013 | Marshbanks Tracy | Executive | Award | 51,778 | $N/A | $0 | |
| Jun 19, 2013 | Marshbanks Tracy | Executive | Award | 1,345,812 | $N/A | $0 | |
| Jun 19, 2013 | Marshbanks Tracy | Executive | Award | 3,314,964 | $N/A | $0 | |
| Jun 19, 2013 | Przybyl Arthur | Executive | Award | 1,966,489 | $N/A | $0 | |
| Jun 19, 2013 | C. Arnold Charlotte | Executive | Award | 595,246 | $N/A | $0 | |
| Jun 19, 2013 | E. Brown Robert Jr | Executive | Award | 16,918,469 | $N/A | $0 | |
| Jun 19, 2013 | G. Marken James | Executive | Award | 435,241 | $N/A | $0 | |
| Jun 19, 2013 | G. Marken James | Executive | Payment | 145,629 | $N/A | $0 | |
| Jun 19, 2013 | J. Jamnick Robert | Executive | Payment | 138,254 | $N/A | $0 | |
| Jun 19, 2013 | J. Jamnick Robert | Executive | Award | 411,964 | $N/A | $0 | |
| Nov 14, 2011 | C. Rosenow Edward III | Executive | Purchase | 3,000 | $2.37 | $7.1K | |
| Aug 15, 2011 | W. Sullivan Louis | Executive | Purchase | 10,000 | $2.67 | $26.7K | |
| Aug 12, 2011 | J. Mangano Ross | Executive | Purchase | 25,000 | $2.40 | $60.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 26 | $997.5K | 75.9% |
Exercise (Options)(X) | 3 | $317.2K | 24.1% |
Award(A) | 12 | $0 | 0.0% |
Payment(F) | 2 | $0 | 0.0% |
Insiders at BIOSANTE PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 15 insiders making 43 transactions totaling $997.5K in purchases versus $0 in sales, the net buying activity of $997.5K signals strong executive confidence. Ross J. Mangano (Executive) leads the buying activity with $1.1M in transactions across all time.